Product Program year 2025 Source: CMS Open Payments

Vitalyst

Device Vitalyst_IC

Open in the dashboard

General payments

$89,746

104 payments

Research payments

$0

0 payments

Through program year 2025, $89,746 in general payments and $0 in research payments were reported against Vitalyst (Vitalyst_IC).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $89,746 104

Breakdown

Who paid General payments · program year 2025
  1. Boston Scientific Corporation $89,746 104 payments
Top recipients General payments · program year 2025
  1. Kevin Croce Cardiovascular Disease · Chestnut Hill, MA $19,820 22% · 7 payments
  2. Brian Bergmark Cardiovascular Disease · Boston, MA $5,194 6% · 4 payments
  3. Grant Reed Interventional Cardiology · Cleveland, OH $5,118 6% · 5 payments
  4. Hector Tamez Aguilar Interventional Cardiology · Boston, MA $5,101 6% · 4 payments
  5. Kamran Muhammad Interventional Cardiology · Tulsa, OK $4,909 5% · 3 payments

The top 5 of 39 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $51,453 60% · 24 practitioners
  2. Cardiovascular Disease Internal Medicine $33,613 39% · 10 practitioners
  3. Advanced Heart Failure and Transplant Cardiology Internal Medicine $209 <1% · 2 practitioners
  4. Family Medicine $169 <1% · 1 practitioner
  5. Internal Medicine $33 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Massachusetts $30,287 34% · 4 recipients
  2. Ohio $13,565 15% · 3 recipients
  3. Nevada $9,248 10% · 2 recipients
  4. Georgia $7,144 8% · 3 recipients
  5. Minnesota $6,711 7% · 7 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

104 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record